Sun Pharmaceutical Industries Ltd on Thursday reported a net profit of ₹2,022.54 crore for the quarter ended June 2023, down 1.86% from ₹2,060.88 crore in the same period last year. The fall in the net profit for the quarter was partly due to one-time charges totaling ₹323 crore.
The company’s revenue from operations in Q1FY24 rose 10.95% to ₹11,940.84 crore from ₹10,761.76 crore in the year-ago quarter. Earnings before interest, taxes, depreciation and amortization (EBITDA) during the quarter increased 27.4% to ₹3,332 crore from ₹2,614.4 crore, YoY, EBITDA margin expanded by 230 basis points (bps) to 27.9% from 25.6%, YoY.
Read more on livemint.com